Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

BACKGROUND: The emergence of new SARS-CoV-2 has promoted the development of new serological tests that could be complementary to RT-PCR. Nevertheless, the assessment of clinical performances of available tests is urgently required as their use has just been initiated for diagnose. OBJECTIVES: The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicol, Thomas, Lefeuvre, Caroline, Serri, Orianne, Pivert, Adeline, Joubaud, Françoise, Dubée, Vincent, Kouatchet, Achille, Ducancelle, Alexandra, Lunel-Fabiani, Françoise, Le Guillou-Guillemette, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295485/
https://www.ncbi.nlm.nih.gov/pubmed/32593133
http://dx.doi.org/10.1016/j.jcv.2020.104511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295485/
https://www.ncbi.nlm.nih.gov/pubmed/32593133
http://dx.doi.org/10.1016/j.jcv.2020.104511

Ejemplares similares